Armata Pharmaceuticals (ARMP) Receivables (2016 - 2017)
Historic Receivables for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q1 2017 value amounting to $15000.0.
- Armata Pharmaceuticals' Receivables rose 714.29% to $15000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $15000.0, marking a year-over-year increase of 714.29%. This contributed to the annual value of $12000.0 for FY2016, which is 9040.0% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Receivables of $15000.0 as of Q1 2017, which was up 714.29% from $12000.0 recorded in Q4 2016.
- Armata Pharmaceuticals' Receivables' 5-year high stood at $136000.0 during Q2 2014, with a 5-year trough of $8000.0 in Q4 2013.
- In the last 5 years, Armata Pharmaceuticals' Receivables had a median value of $21000.0 in 2016 and averaged $44250.0.
- Its Receivables has fluctuated over the past 5 years, first skyrocketed by 115000.0% in 2014, then tumbled by 9040.0% in 2016.
- Armata Pharmaceuticals' Receivables (Quarter) stood at $8000.0 in 2013, then soared by 1150.0% to $100000.0 in 2014, then increased by 25.0% to $125000.0 in 2015, then tumbled by 90.4% to $12000.0 in 2016, then increased by 25.0% to $15000.0 in 2017.
- Its last three reported values are $15000.0 in Q1 2017, $12000.0 for Q4 2016, and $24000.0 during Q3 2016.